Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed B-cell NHL”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchLooking for participantsNCT07093411
What this trial is testing

Targeting CD19/CD20 Dual-targeted Cell in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
B-cell Non-Hodgkin Lymphoma Recurrent B-cell Non-Hodgkin Lymphoma Refractory
Beijing GoBroad Hospital 48
Testing effectiveness (Phase 2)WithdrawnNCT01101581
What this trial is testing

Study of Veltuzumab and 90Y-Epratuzumab in Relapsed/Refractory, Aggressive NHL

Who this might be right for
Non Hodgkin's LymphomaNHLAggressive NHL+1 more
Gilead Sciences
Early research (Phase 1)UnknownNCT03344367
What this trial is testing

Study Evaluating the Safety and Efficacy of JWCAR029 in Adult Subjects With Relapsed and Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
Non Hodgkin Lymphoma
Peking University 20
Testing effectiveness (Phase 2)Study completedNCT01148108
What this trial is testing

Study of Canfosfamide in Refractory or Relapsed Mantle Cell, Diffuse Large B Cell Lymphoma and Multiple Myeloma

Who this might be right for
Mantle Cell LymphomaB Cell LymphomaMultiple Myeloma
Telik 14
Early research (Phase 1)Study completedNCT02669017
What this trial is testing

Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL)

Who this might be right for
Non-Hodgkin LymphomaBurkitt's LymphomaChronic Lymphocytic Leukemia+6 more
ADC Therapeutics S.A. 183
Early research (Phase 1)Looking for participantsNCT05685173
What this trial is testing

A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas

Who this might be right for
B-cell Non-Hodgkins Lymphoma (B-NHL)
Regeneron Pharmaceuticals 107
Testing effectiveness (Phase 2)Study completedNCT00365287
What this trial is testing

Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer

Who this might be right for
Breast CancerKidney CancerLeukemia+3 more
Masonic Cancer Center, University of Minnesota 148
Early research (Phase 1)Study completedNCT01729806
What this trial is testing

Ipilimumab and Rituximab in Treating Patients With Relapsed or Refractory B-cell Lymphoma

Who this might be right for
CD20 PositiveRecurrent B-Cell Non-Hodgkin LymphomaRefractory B-Cell Non-Hodgkin Lymphoma
National Cancer Institute (NCI) 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT02952508
What this trial is testing

Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in Waldenstrom

Who this might be right for
Waldenstrom MacroglobulinemiaMultiple MyelomaChronic Lymphocytic Leukemia+6 more
Cellectar Biosciences, Inc. 120
Testing effectiveness (Phase 2)Ended earlyNCT06561425
What this trial is testing

A Study Evaluating the Safety and Efficacy of GLPG5101 (19CP02) in Participants With Non-Hodgkin Lymphoma

Who this might be right for
Relapsed/Refractory B-cell Non-Hodgkin LymphomaLymphomas Non-Hodgkin&Amp;Amp;#39;s B-Cell
Lakefront Biotherapeutics NV 130
Testing effectiveness (Phase 2)Study completedNCT01261247
What this trial is testing

Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+18 more
Mayo Clinic 41
Testing effectiveness (Phase 2)Study completedNCT00918333
What this trial is testing

Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+25 more
Mayo Clinic 124
Early research (Phase 1)Study completedNCT01403415
What this trial is testing

Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma

Who this might be right for
Childhood B Acute Lymphoblastic LeukemiaChildhood T Acute Lymphoblastic LeukemiaMature T-Cell and NK-Cell Non-Hodgkin Lymphoma+2 more
National Cancer Institute (NCI) 13
Very early researchUnknownNCT04532268
What this trial is testing

Humanized CD19 CAR-T Cells Therapy for Patients With Relapsed and/or Refractory B-cell ALL and B-cell NHL

Who this might be right for
Acute Lymphoblastic LeukemiaNon-hodgkin Lymphoma,B Cell
Zhejiang University 72
Early research (Phase 1)Study completedNCT00002818
What this trial is testing

High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic Malignancies

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLeukemiaLymphoma+1 more
Virginia Commonwealth University 15
Early research (Phase 1)Study completedNCT00962507
What this trial is testing

Panobinostat and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma

Who this might be right for
LymphomaMultiple Myeloma and Plasma Cell Neoplasm
City of Hope Medical Center 11
Very early researchLooking for participantsNCT06446128
What this trial is testing

A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed or Refractory B Cell Non-Hodgkin Lymphoma(NHL)

Who this might be right for
Non-Hodgkin Lymphoma, B-cell
Shanghai Cell Therapy Group Co.,Ltd 20
Early research (Phase 1)Study completedNCT03263637
What this trial is testing

Study to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological Malignancies

Who this might be right for
Relapsed or Refractory Haematological Malignancies IncludingAcute Myeloid LeukemiaAcute Lymphocytic Leukemia+8 more
AstraZeneca 44
Testing effectiveness (Phase 2)Study completedNCT01995669
What this trial is testing

Lenalidomide and Obinutuzumab in Treating Patients With Relapsed Indolent Non-Hodgkin Lymphoma

Who this might be right for
Grade 3a Follicular LymphomaRecurrent Follicular LymphomaRecurrent Grade 1 Follicular Lymphoma+7 more
M.D. Anderson Cancer Center 66
Early research (Phase 1)Looking for participantsNCT07451054
What this trial is testing

CD45BE-HSPC + CART-45 Cells

Who this might be right for
B-Cell Non-Hodgkin Lymphoma (NHL)Richter's TransformationT-Cell Non-Hodgkin Lymphoma+1 more
University of Pennsylvania 42
Next Page